Bayer Schering Pharma AG v. Teva Pharmaceuticals USA Inc.
1:09-cv-00682
Overview
Parties
Defendant
Teva Pharmaceuticals USA Inc. Operating Company
Represented By
1 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
0 Attorneys ListedBayer Schering Pharma AG Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell
Morris, Nichols, Arsht & Tunnell, 1201 North Market Street
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Bayer HealthCare Pharmaceuticals Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell
Morris, Nichols, Arsht & Tunnell, 1201 North Market Street
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Schering Corporation NPE (Individual / Inventor)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell
Morris, Nichols, Arsht & Tunnell, 1201 North Market Street
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 15 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6362178
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
|
Filed: 1998-10-31
Issued: 2002-03-26
|
Expired (Term Ended)
Expires: 2018-10-31
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).